Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

Keywords

Huntington's disease, Oxidative stress, Disease, Neuroscience, Biology

References

• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.広和 篠崎, 芳彰 工藤, 繁 古屋 — 1997
• Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin洋一 野々垣, 重晴 鈴木, 洋揮 大熊 — 1999
• From Cytoprotection to Tumor Suppression: The Multifactorial Role of PeroxiredoxinsRobert M. Ortega — 1999
• Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions.Toru Iwaki, Thomas Wısnıewskı, Akiko Iwaki — 1992
• MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.George Bartzokis, T A Tishler — 2000
• Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)Lawrence F. Eng, Roopa S. Ghirnikar, Yuen L. Lee — 2000
• Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease.Mark Head, E Corbin, J. E. Goldman — 1993
• Selenium and selenoproteins in the brain and brain diseasesJun Chen, Marla J. Berry — 2003
• Carbonyl assays for determination of oxidatively modified proteins.Rodney L. Levine, Joy Williams, Earl P. Stadtman — 1994
• Influence of Huntington's disease on the human and mouse proteome.Claus Zabel, Joachim Klose — 2004
• Increased infarct size and exacerbated apoptosis in the glutathione peroxidase‐1 (Gpx‐1) knockout mouse brain in response to ischemia/reperfusion injuryPeter J. Crack, Juliet M. Taylor, Nicole J. Flentjar — 2001
• Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3Dorotea Rigamonti, Johannes H. Bauer, Claudio De‐Fraja — 2000
• Huntingtin inclusion bodies are iron‐dependent centers of oxidative eventsWance Firdaus, Andreas Wyttenbach, Paola Giuliano — 2006
• Oxidative stress during aging of stationary cultures of the yeast Saccharomyces cerevisiae.Witold Jakubowski, Tomasz Biliński, Grzegorz Bartosz — 2000
• The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's diseaseSusan E. Andrew, Y. Paul Goldberg, Berry Kremer — 1993
• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.Joan S. Steffan, Aleksey Kazantsev, Olivera Spasić-Bošković — 2000
• Mitochondrial Hsp60, Resistance to Oxidative Stress, and the Labile Iron Pool Are Closely Connected in Saccharomyces cerevisiae *Elisa Cabiscol, Gemma Bellı́, Jordi Tamarit — 2002
• Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's diseaseJavier Benı́tez, Esther Fernández, Pedro Ruiz — 1994
• The kynurenine pathway of tryptophan degradation as a drug target.Robert Schwarcz — 2004
• Cortical glucose metabolism in Huntington's diseaseW. R. Wayne Martin, Campbell Clark, W. Ammann — 1992

Cited by

• Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future ApplicationsMehdi Joseph-Ouni, Roger Bour, William P. McCord — 2012
• The choreography of neuroinflammation in Huntington’s diseaseAndrea Crotti, Christopher K. Glass — 2015
• Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.沈政 — 2017
• Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's diseaseSusan Ballyn — 2016
• Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.Chiung‐Mei Chen — 2011
• Alterações neurogliais em ratos expostos ao ácido ocadáico como modelo de demênciaAna Paula Costa — 2011
• The role of mitochondrial dysfunction in Huntington's disease: pathogenesis and its relation with striatal Rhes proteinM Argenti — 2014
• Rôle de la dysfonction mitochondriale dans deux maladies neurodégénératives, la Maladie de Huntington et la Maladie de ParkinsonM. Damiano — 2014
• CHARACTERIZING THE FUNCTION OF HUNTINGTIN IN THE CELL STRESS RESPONSE AS A TARGET FOR DRUG DISCOVERY IN HUNTINGTON’S DISEASELise N. Munsie — 2012
• Knowledge derivation and data mining strategies for probabilistic functional integrated networksKatherine James — 2012
• Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease.Irene Ciancarelli — 2015
• Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)Koji Aoyama, Toshio Nakaki — 2015
• Besides Huntington's disease, does brain-type creatine kinase play a role in other forms of hearing impairment resulting from a common pathological cause?Yow‐Sien Lin, Chih‐Hung Wang, Yijuang Chern — 2011
• Analysis of Oxidative Damage by Gene‐Specific Quantitative PCROlga A. Kovalenko, Janine H. Santos — 2009
• Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive ImpairmentFrancesca Mangialasche, Mauro Baglioni, Roberta Cecchetti — 2015
• Metabolism in HD - Still a relevant mechanism?Wenzhen Duan, Mali Jiang, Jing Jin — 2014
• β-cell dysfunction in Huntington's diseaseKarl Bacos — 2009
• Protein carbonylation: proteomics, specificity and relevance to aging.Elisa Cabiscol, Jordi Tamarit, Joaquim Ros — 2014
• Selenium and selenoprotein function in brain disordersRoshan Pillai, Jane Uyehara‐Lock, Frederick P. Bellinger — 2014
• NUB1 suppression of Huntington toxicity: mechanistic insightsBoxun Lu, Yao Yao — 2015

Related papers

• Long-term follow-up of craniofacial alterations in juvenile idiopathic arthritis.Antonio Rodríguez‐Ariza — 2009
• A proteomic approach to the myocardium of hypertensive-diabetic ratsÓscar Lorenzo, Irene Zubiri, S. Ares-Carrasco — 2009
• A proteomic approach acute and chronic phase of chagas disease AutorMartha Lucía Díaz, Aldo Solari, Clara Isabel González — 2009
• Quantitative analysis of protein glycation in clinical samplesFeliciano Priego‐Capote, Alexander Scherl, Yohann Couté — 2009
• Cell signaling proteomics in colorectal cancerJuan Madoz‐Gúrpide, Francisco Fernández-Carbonié, Patricia Alfonso — 2008
• Proteomic analysis of degradation pathways in rodococcus SP. strain TFBLaura Tomás‐Gallardo, Eduardo Santero, Emilio Camafeita — 2009
• Glycated platelets proteomeM. Ramírez-Boo, Feliciano Priego‐Capote, Christine Hoogland — 2011
• Proteomics and metabolomics off human atherosclerotic arteriesFernando Vivanco — 2009
• Peptide fractionation for the proteomics studiesLázaro Betancourt, Aniel Sánchez, Jeovanis Gil — 2009
• From liver tissue to phosphorylation sitesEva Rodríguez‐Suárez, Asier Galan Cousillas, Félix Elortza — 2008